greeksoup/ stock research
Stock research / United States / ANIK / Planned sales

Anika Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Anika Therapeutics, Inc. filed 1 Form 144 notice of planned sales, 16,864 shares worth $355,255 at the time of filing, from 1 seller. The latest, filed 7 August 2026: Jellison William R (former director), 16,864 shares worth $355,255, planned for around 7 August 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
7 August 2026Jellison William RFormer Director16,864$355,2557 August 2026None on Form 4 yetFidelity Brokerage Services LLCOpen Market Purchase; Restricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?